Prepackaged diet

NEW YORK, July 27 (Praxis Press) Roughly 55% of persons aged 20 years or older in the United States are obese or overweight and weight reduction remains the first-line treatment strategy. Metz and colleagues assessed the long-term effects of two types of diet: a prepackaged, nutritionally complete, prepared meal plan and a usual-care diet (UCD), based on patient choices made from an approved list of substitutions. They compared the effects of the two diets on weight loss and cardiovascular risk

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, July 27 (Praxis Press) Roughly 55% of persons aged 20 years or older in the United States are obese or overweight and weight reduction remains the first-line treatment strategy. Metz and colleagues assessed the long-term effects of two types of diet: a prepackaged, nutritionally complete, prepared meal plan and a usual-care diet (UCD), based on patient choices made from an approved list of substitutions. They compared the effects of the two diets on weight loss and cardiovascular risk factors in overweight and obese persons. To perform the study they randomized 183 persons with hypertension/dyslipidemia and 119 persons with type 2 diabetes mellitus to the prepared meal plan or to the UCD. After one year, weight change in the hypertension/dyslipidemia group was -5.8kg with the prepared meal plan vs -1.7kg with the UCD plan; for the type 2 diabetes mellitus group, the change was -3.0kg with the prepared meal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform